Meissner Corporation has invested US$250 million in the development of a new manufacturing site in Athens-Clarke County, Georgia, USA.
The project will generate nearly 1,700 new jobs over the next eight years.
Meissner's new facility will be located at 1310 Spring Valley Road in Winterville, in the Christian Industrial Tract.
The product range of the company enables the development and production of key medications in therapeutic areas such as oncology, cardiology, and immunology.
The company's upcoming expansion will result in a significant increase in its production capabilities within the United States, surpassing its current footprint.
Upon completion of the planned phases, the new campus located in Athens-Clarke County is expected to more than double the company's existing facilities.
The site will consist of various modern structures, including cutting-edge cleanroom facilities, laboratories, research and development areas, and office spaces.
Operations at the new building are scheduled to begin in early 2026.